Major Depressive Disorder

Disease State Hub

Research Summaries

Research Summary

Low Prevalence of Depression in Children from 2004 to 2019

01/18/2024

Jessica Ganga

Researchers evaluated the prevalence of depression disorders in pediatric patients to determine if there is a mental health impact on this age group.

01/18/2024

Research Summary

Research Summary

Association of Major Depression With Oral Contraceptive Pill Use

01/03/2024

Jessica Ganga

A team of researchers evaluated the connection between oral contraceptive pill use and the prevalence of major depression in women.

01/03/2024

FDA Alert

FDA Approves First Oral Medication for Treatment of Postpartum Depression

10/04/2023

Jessica Ganga

Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.

10/04/2023

Research summary

Research summary

USPSTF Recommendations on Screening for MDD, Suicide Risk in Adults

07/28/2023

Jessica Ganga

The USPSTF has updated its recommendations on screening adults for major depressive disorder (MDD) and suicide risk.

07/28/2023

conference coverage

Depression, Anxiety in PWH Increases Myocardial Infarction Risk

03/16/2023

In a new study presented at CROI 2023, researchers examined how depression and anxiety in individuals with HIV impacts the risk of incident acute myocardial infarction in this patient population.

03/16/2023

Research Summary

ACP Updates MDD Treatment Guidelines

02/15/2023

The American College of Physicians updated its recommendations on pharmacologic and nonpharmacologic treatment options for adults with major depressive disorder.

02/15/2023

Research Summary

ACP Updates MDD Treatment Guidelines

02/15/2023

The American College of Physicians updated its recommendations on pharmacologic and nonpharmacologic treatment options for adults with major depressive disorder.

02/15/2023

Electroconvulsive Therapy

Electroconvulsive Therapy Potentially a Better Option in Treating Major Depressive Episodes Than Ketamine

01/05/2023

Researchers conducted a systematic review to compare the treatment efficacy and safety of ketamine and electroconvulsive therapy.

01/05/2023

Conference Coverage

Diagnosis, Management Strategies for Treatment-Resistant Depression

11/18/2022

This article summarizes a presentation on treatment-resistant depression by Manish Jha, MBBS, at Practical Updates in Primary Care 2022 Virtual Series.

11/18/2022

Conference Coverage

Evolving Management Strategies in MDD: Smarter Choices After Unsuccessful First-Line Treatment

10/14/2022

Implementing the best treatment strategies is important when treating a patient with major depressive disorder (MDD), especially if first-line treatment fails. This article summarizes a presentation on...

10/14/2022

Major Depressive Disorder Snapshot

For more mental health content, visit the Resource Center

For a period of at least 2 weeks, an individual maintains a depressed mood, which may involve feelings of guilt or worthlessness, lack of energy, poor concentration, appetite changes, agitation, sleep disturbances, or suicidal thoughts.

For more psychology content, visit the Resource Center

clinical psychologists, psychiatrists, primary care physicians, emergency medicine, social workers

For more perspective from key opinion leaders in mental health, visit the Clinical Insights page

One must have at least 5 symptoms from this list: depressed mood, inability to experience pleasure, feelings of guilt or worthlessness, lack of energy, poor concentration, appetite changes, agitation, sleep disturbances, or suicidal thoughts

For more perspective on major depression disorder, visit the Clinical Insights page

(continued) From that list, one of the symptoms must be a depressed mood or inability to experience pleasure in order to be diagnosed with MDD.

Ref: https://www.ncbi.nlm.nih.gov/books/NBK559078/

For more patient education content, visit the Resource Center

The Patient Health Questionnaire-9 (PHQ-9): Used to quantify severity and assist in diagnosis of depression symptoms. PHQ-9 scores each of the DSM criteria of MDD as “0” (not at all) to “3” (nearly every day), providing a 0-27 severity score.

For more patient safety content, visit the Resource Center

Hamilton Rating Scale for Depression (HAM-D): clinician-administered depression rating scale commonly used to measure depression in adults. Of the 21 items on the scale, only the first 17 are used for scoring.

For more perspective from leaders in psychology, visit the Clinical Insights page

(continued) Other tests include: Beck Depression Inventory, Zung Self-Rating Depression Scale, Geriatric Depression Scale, Center for Epidemiologic Studies-Depression Scale

For more primary care content, visit the Resource Center

In 2021, an estimated 21 million adults in the United States had at least one major depressive episode, representing an estimated 8.3% of all U.S. adults.

for more public health content, visit the Resource Center

The US Preventive Services Task Force recommends that all adults—including those pregnant and postpartum—be screened for depression.

For more pediatrics content, visit the Resource Center

The percentage of female high school students who experienced persistent feelings of sadness or hopelessness in 2021 was 57%, a record level and double the rate of males.

Research Summaries

Research Summary

Low Prevalence of Depression in Children from 2004 to 2019

01/18/2024

Jessica Ganga

Researchers evaluated the prevalence of depression disorders in pediatric patients to determine if there is a mental health impact on this age group.

01/18/2024

Research Summary

Association of Major Depression With Oral Contraceptive Pill Use

01/03/2024

Jessica Ganga

A team of researchers evaluated the connection between oral contraceptive pill use and the prevalence of major depression in women.

01/03/2024

Research summary

USPSTF Recommendations on Screening for MDD, Suicide Risk in Adults

07/28/2023

Jessica Ganga

The USPSTF has updated its recommendations on screening adults for major depressive disorder (MDD) and suicide risk.

07/28/2023

Research Summary

ACP Updates MDD Treatment Guidelines

02/15/2023

The American College of Physicians updated its recommendations on pharmacologic and nonpharmacologic treatment options for adults with major depressive disorder.

02/15/2023

Electroconvulsive Therapy

Electroconvulsive Therapy Potentially a Better Option in Treating Major Depressive Episodes Than Ketamine

01/05/2023

Researchers conducted a systematic review to compare the treatment efficacy and safety of ketamine and electroconvulsive therapy.

01/05/2023

April 2024

Current Issue

April 2024

Volume 64

Issue 4

Sources:

https://www.ncbi.nlm.nih.gov/books/NBK559078/
https://www.nimh.nih.gov/health/statistics/major-depression
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.
https://www.med.upenn.edu/cbti/assets/user-content/documents/Hamilton%20Rating%20Scale%20for%20Depression%20(HAM-D).pdf
Centers for Disease Control and Prevention. Youth behavior risk survey: data summary and trends report. Accessed March 31, 2023. https://www.cdc.gov/healthyyouth/data/yrbs/yrbs_data_summary_and_trends.htm